A Guide to Switching from Mounjaro to Wegovy in the UK

If you are currently using Mounjaro for weight management, you might be considering a switch to Wegovy. This is a common consideration for many patients in the UK, often based on practical factors such as long-term cost and reliable supply.

For many, Wegovy is proving to be a more financially sustainable option, making a potential switch a sensible topic of discussion with a healthcare professional.

Why Are Patients Switching from Mounjaro to Wegovy?

Choosing to switch between prescription treatments like Mounjaro and Wegovy is a significant decision in your weight management journey. This guide provides factual information to help you understand the process, which must always be undertaken under the supervision of a qualified prescriber from a UK-registered pharmacy.

Both Mounjaro and Wegovy are MHRA-approved, prescription-only injections for weight management. However, they are not identical. Mounjaro’s active ingredient is tirzepatide, while Wegovy’s is semaglutide. While both are incretin mimetics, tirzepatide is a dual-agonist, acting on two hormone receptors (GIP and GLP-1), whereas semaglutide is a single-agonist, focusing on the GLP-1 receptor.

To help you see the differences, here is a comparison of the two medications.

Mounjaro vs Wegovy at a Glance

This table provides a high-level view, but the reasons people switch often extend beyond the clinical details.

Understanding the Key Drivers for Change

For many people in the UK, the discussion about switching is not about one medication being superior to the other. It is about practical factors that influence the sustainability of ongoing treatment. The two biggest drivers are cost and supply consistency.

Recent changes in the private healthcare market have affected the affordability of these treatments. Price adjustments for Mounjaro, in particular, have prompted many to seek a more predictable, cost-effective option for their continuing care.

In September 2024, following a significant price rise for Mounjaro in the private market, one UK provider reported a 2,660% increase in Wegovy sales. This indicated that patients were actively seeking a more affordable, yet still clinically effective, alternative. You can read more about this trend and its implications for UK patients in this report from The Independent.

This highlights that switching from Mounjaro to Wegovy is often a pragmatic choice. Patients are not abandoning their health goals; they are finding a more sustainable way to achieve them.

The Importance of Clinical Oversight

Making this change is not something you should do independently. A thorough clinical assessment is essential to ensure the switch is safe and appropriate for your specific health situation.

A UK-registered prescriber will need to review several key factors before authorising a switch:

• Your experience with Mounjaro, including its effectiveness and any side effects you experienced.
• Your complete health profile and medical history.
• The correct starting dose of Wegovy to ensure a safe and smooth transition.

Professional oversight ensures your weight management continues without interruption. Using a regulated online pharmacy, which is overseen by bodies such as the GPhC (General Pharmaceutical Council), provides a secure and convenient way to manage the switch with expert guidance. This guide will outline the steps, what to expect, and how to have a productive discussion with your clinician.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.

How Do Mounjaro and Wegovy Actually Compare?

If you are considering switching from Mounjaro to Wegovy, one of your first questions might be whether you are moving to a less effective treatment. It is a valid concern. You want to ensure you are transitioning to a medication that is equally effective for your weight management journey. Let's examine the scientific evidence and real-world results, which should be discussed with a qualified clinician.

Both medications are classified as incretin mimetics. In simple terms, they mimic the hormones your body naturally uses to regulate appetite and blood sugar. While they belong to the same class of drugs, they do not have identical mechanisms of action.

The Different Mechanisms Behind the Medicines

Wegovy’s active ingredient is semaglutide. It is known as a GLP-1 (glucagon-like peptide-1) receptor agonist. It specifically targets GLP-1 receptors in the brain to reduce hunger signals and slows gastric emptying, which helps you feel fuller for longer and can lead to a reduction in calorie intake. This targeted approach is highly effective for long-term weight management.

Mounjaro, on the other hand, uses tirzepatide. This is a dual-agonist, meaning it acts on two different receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). By engaging two separate hormonal pathways, Mounjaro provides another powerful mechanism to support weight loss.

While Mounjaro’s dual action is often highlighted, it does not mean Wegovy’s focused GLP-1 action is less effective. Both are first-line treatments, and the most suitable choice often depends on individual response, tolerance of side effects, and practical considerations like availability.

A Look at the Weight Loss Numbers

When comparing medications, we refer to clinical trial data for the clearest picture of expected outcomes. In their respective trials, both Wegovy and Mounjaro have demonstrated significant results.

• Wegovy (Semaglutide): On average, clinical studies show patients taking Wegovy achieve a body weight loss of 15% to 20%.

• Mounjaro (Tirzepatide): Similar studies have shown an average weight loss of around 20% to 23% at the higher doses.

While these numbers may suggest a slight advantage for Mounjaro, this small percentage difference is often not as significant in real-world clinical practice.

Clinical data shows Wegovy achieves an average weight loss of 15-20%, which is comparable to Mounjaro's 20-23%. A small percentage difference is often negligible in real-world patient outcomes, as individual responses to any medication can vary significantly. You can discover more insights about these clinical comparisons on SheMed.co.uk.

This demonstrates that Wegovy is not just a secondary option; it is a robust and effective alternative in its own right. Understanding the full range of approved treatments is key, which is why we created our guide on the best weight loss injections in the UK.

Why Your Individual Response Is What Truly Matters

It is crucial to remember that trial statistics are averages from large populations. Your personal experience may differ. Some patients respond very well to semaglutide, while others find tirzepatide more effective. Your unique genetics, lifestyle, and other health conditions all contribute to how you will respond.

For those interested in the evolving science of these treatments, comparisons like Retatrutide vs Mounjaro offer insights into the next generation of peptide-based medicines.

Therefore, making a switch from Mounjaro to Wegovy is not a step backward. It is a transition to another highly effective, MHRA-approved treatment. The goal is to find the medication that provides you with the best results and fits sustainably into your long-term health plan. This is a decision you will make with your prescriber from a regulated service, such as a UK-registered pharmacy.

Making the Switch: A Safe and Supervised Transition

Considering a switch from Mounjaro to Wegovy is a common query, but it is vital to understand that this is not something you can do independently. It is a carefully managed process that must be guided by a qualified clinician. The transition is designed entirely around your safety.

The primary goal is to minimise potential side effects and allow your body to adjust smoothly to the new active ingredient, semaglutide.

Your first step is to consult a UK-registered prescriber. This can be done through a regulated online pharmacy, where a clinician will conduct a full health assessment. They will need to confirm that moving to Wegovy is a safe and appropriate option for you. Never attempt to switch medications without this professional medical guidance.

The “Washout Period”: Giving Your Body a Break

To ensure a safe switch, your prescriber will recommend a "washout period." This is a planned interval between your final dose of Mounjaro (tirzepatide) and your first dose of Wegovy (semaglutide). This is a standard safety measure in medicine when transitioning between certain types of treatments.

The recommended washout period is a minimum of seven days.

This means you will wait at least one full week after your last Mounjaro injection before starting Wegovy. For example, if your usual Mounjaro injection day is a Tuesday, you would skip a week and take your first Wegovy dose the following Tuesday.

Why is this so important? The washout period allows your body to start clearing the first active ingredient (tirzepatide) before you introduce the new one (semaglutide). Administering them too close together, or concurrently, could significantly increase the risk of side effects such as severe nausea, vomiting, or other gastrointestinal issues.

This timeline illustrates how the process works.

As shown, the washout is a critical safety buffer between stopping Mounjaro and starting Wegovy.

Resetting Your Dose: Starting Low and Slow

One of the most frequent questions from patients concerns the starting dose of Wegovy. This is where clinician oversight is non-negotiable for your safety.

The key principle is: regardless of your final Mounjaro dose, you will almost always begin Wegovy at its lowest possible dose: 0.25 mg.

This may seem counterintuitive, especially if you were on a much higher dose of Mounjaro. A patient who was stable on a 10 mg or even 15 mg dose of Mounjaro will still need to start their Wegovy treatment at the 0.25 mg introductory dose.

This "reset" is a core safety principle. Although they are both injectable weight loss treatments, their active ingredients differ, and your body needs to acclimatise to semaglutide gradually. Starting at a higher dose would dramatically increase the likelihood of significant and unpleasant side effects.

A Real-World Switching Scenario

Let’s consider a typical example. A patient, Sarah, has been using Mounjaro 7.5 mg once a week. She consults her clinician at a UK-registered pharmacy and decides to switch to Wegovy for cost reasons.

Her transition plan would look like this:

• Final Mounjaro Dose: Sarah takes her last 7.5 mg Mounjaro injection on a Sunday morning.
• The Washout Week: She takes no injections for the next seven days. During this week, the tirzepatide levels in her system begin to decline.
• First Wegovy Dose: On the following Sunday morning, she administers her first Wegovy injection at the starting dose of 0.25 mg.
• Titration Begins: From here, Sarah follows the standard Wegovy dose-escalation schedule. She will increase the strength approximately every four weeks, provided she is tolerating the medication well.

This structured approach ensures the changeover is as smooth as possible. It protects you from potential adverse effects while allowing your body to adapt properly to the new prescription-only treatment. To see how this works within a regulated service, you can review our guide on getting a UK online doctor prescription.

Ultimately, every step of switching from Mounjaro to Wegovy is carefully planned and supervised. Your prescriber will provide a personalised plan and will be available to support you as you begin your new treatment, ensuring your weight management journey continues safely and effectively.

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting or changing any treatment.

Managing Your New Wegovy Dosing and Side Effects

Once you have completed the washout period, you are ready to begin treatment with Wegovy. Your body now needs to become accustomed to semaglutide, and the key to this is the dosing schedule. This is not merely a guideline; it is a critical safety measure designed to help your body acclimatise and minimise side effects.

Wegovy uses a titration schedule, which means you will start on the lowest dose and increase the strength every four weeks. This slow and steady approach is vital, and it is a process you will follow even if you were on the highest dose of Mounjaro. Your body is encountering a new medication, so a fresh, careful start is the only safe approach.

The Wegovy Titration Journey

The dose escalation for Wegovy is predictable. Each strength comes in a different coloured pen, which provides a visual way to track your progress. A clinician will guide you, ensuring you only move up to the next dose when you are feeling well and tolerating the current one.

The typical monthly plan is as follows:

• Month 1: 0.25 mg once weekly (your starting dose)
• Month 2: 0.5 mg once weekly
• Month 3: 1.0 mg once weekly
• Month 4: 1.7 mg once weekly
• Month 5 Onwards: 2.4 mg once weekly (your maintenance dose)

The goal for most people is to reach the 2.4 mg maintenance dose. Clinical trials have shown this is the most effective strength for sustained weight management. However, your safety and comfort are paramount. If side effects are proving difficult, your prescriber might suggest remaining on a lower dose for an additional month or two.

Understanding and Managing Potential Side Effects

When moving from Mounjaro to Wegovy, your body may react differently. While the side effects are often similar, your personal experience with semaglutide could differ from how you felt on tirzepatide.

The most common issues are gastrointestinal, such as nausea, diarrhoea, constipation, or stomach upset. These are usually mild and tend to diminish as your body adjusts.

Common side effects of Wegovy can include:

• Nausea
• Diarrhoea or constipation
• Indigestion or acid reflux
• Stomach ache
• Fatigue

You are most likely to notice these when you first start or just after a dose increase. Fortunately, a few practical adjustments can make a significant difference.

From clinical experience, keeping a simple symptom diary for the first few weeks can be incredibly useful. Note down what you eat, when you feel unwell, and the intensity. This gives your clinician a clear picture and helps them provide the best advice at your next check-in.

Practical Tips for Better Tolerability

Managing side effects is an active process. Small changes to your daily routine can have a large impact on your comfort and help you adhere to the treatment. We always provide patients with detailed advice, but here are some of the most effective strategies.

• Eat Smaller, More Frequent Meals: A large meal can be a shock to a system with slowed digestion. Spreading smaller portions throughout the day is gentler on your stomach and helps prevent nausea.

• Stay Well-Hydrated: Sipping water throughout the day is a simple but powerful habit. Dehydration can worsen headaches and fatigue, so keeping a water bottle nearby is advisable.

• Choose Bland Foods: If you feel nauseous, stick to basics like toast, rice, or plain crackers, which are easy on the stomach. It is best to avoid greasy, spicy, or very rich foods until you feel better.

• Listen to Your Body: Wegovy is designed to enhance satiety signals. Pay close attention to these cues and stop eating when you feel satisfied, not full.

It is very important to maintain an open dialogue with your prescriber, especially if side effects feel severe or do not improve. They are your partner in this process, ready to offer medical support or adjust your plan. All prescribed medication requires this kind of ongoing clinical oversight, and using a service that is regulated by the GPhC ensures you have that support when you need it.

Your Consultation: How to Discuss the Switch with a Clinician

Thinking about switching from Mounjaro to Wegovy is a significant decision. Your next, and most important, step is to have a proper discussion with a UK-registered prescriber. This is not a box-ticking exercise; it is a crucial conversation to ensure your weight management journey continues safely and effectively.

Whether you are meeting your clinician in person or via video call, a little preparation goes a long way. This is your chance to combine your real-world experience on the medication with their clinical expertise. It is a partnership.

Getting Ready for Your Consultation

To get the most out of your appointment, it helps to organise your thoughts beforehand. Your clinician will guide the discussion, but having your own notes ensures you do not forget to mention something important.

Here is what you should be ready to talk about:

• Your Time on Mounjaro: Be open about the positive and negative aspects. How has your weight loss progressed? What side effects have you had, and were they manageable?
• Your Reasons for Switching: What is prompting this change? Is it the cost, concerns about supply, or were the side effects difficult to manage? There are no wrong answers.
• Your Overall Health: Your clinician needs a complete picture. Be ready to discuss your medical history, any other health conditions you have, and all medications you are currently taking.
• Your Questions and Concerns: Are you nervous about starting Wegovy? Concerned the side effects might be different or that your weight loss might stall? Write these down so you remember to ask.

The Clinician’s Role in a Safe Switch

During your consultation, your prescriber's top priority is your health and safety. They will carry out a thorough assessment to ensure Wegovy is a suitable and safe prescription-only treatment for you. This is a regulated process, particularly when using a UK-registered pharmacy service, and it is designed to protect you.

The clinician will review your current health, BMI, and medical history to check for any contraindications—that is, specific medical reasons why Wegovy might not be right for you. This is a vital safety check.

The UK landscape for these treatments is changing rapidly. Between 2024 and 2025, an estimated 1.6 million UK adults used weight loss injections, many of whom were on Mounjaro. With another 3.3 million considering them, the reasons for starting or switching can vary widely. You can find more on these trends in the full UCL report.

Ultimately, your prescriber must evaluate your individual clinical situation. They will listen to your preferences, but the final decision will always be based on what is medically appropriate for you.

Using an Online Pharmacy for Your Consultation

Many people now manage their health online, and discussing a medication switch is no different. Using an online pharmacy provides a convenient and discreet way to access expert advice from a UK-registered clinician. Reputable platforms, which are regulated by the GPhC, follow strict safety protocols.

When you use a service like XO Medical, the process is designed to be comprehensive. You will complete a detailed online health questionnaire, which allows you to be more thorough than you might be in a brief, face-to-face consultation. A clinician then carefully reviews your information to determine if the switch is safe, provides your new prescription, and gives you a clear plan for making the change.

This modern approach keeps you in control of your health journey, with the full backing and safety of a regulated medical professional. To see what this involves, take a look at our guide on how a UK online doctor consultation works.

Common Questions About Switching From Mounjaro to Wegovy

Considering a switch from Mounjaro to Wegovy is a significant decision, and it is normal to have many questions. To help you prepare for a conversation with your clinician, here are answers to some of the most common queries from patients in the UK considering this change.

Will I Have to Start from the Lowest Dose Again?

Yes, almost certainly. Even if you were on a high dose of Mounjaro, you will start Wegovy at the very beginning, with the 0.25 mg introductory dose.

This is not a step backward; it is a crucial safety measure. Because Wegovy’s active ingredient (semaglutide) is different from Mounjaro’s (tirzepatide), your body needs time to adjust. This gradual approach is the best way to minimise side effects like nausea and ensure your transition is as smooth as possible. Any prescriber at a UK-registered pharmacy will insist on this for your safety.

What if Wegovy Isn’t for Me? Can I Switch Back?

Yes, switching back is an option, but it must be managed with the same clinical care as the initial switch. If you find Wegovy is not a good fit—perhaps the side effects are persistent or it is not effective for you—you can discuss returning to Mounjaro with your prescriber.

The process is similar. You would need to observe a "washout period" to allow the Wegovy to clear your system before restarting Mounjaro. Your clinician would then determine the most appropriate starting dose based on how long you were off it and other factors.

Your weight management journey is highly personal. The goal is to find the prescribed medication that works best for you and your body long-term. A clinical team can help you find that fit, whether it is Wegovy, Mounjaro, or another option.

Will I Put Weight on During the Switch?

This is one of the most common concerns. It is possible you may see a temporary pause in weight loss or even a slight gain during the transition, but this is usually temporary and should not cause alarm.

Between the one-week washout and starting on Wegovy’s lowest dose, there is a short window where the level of active medication in your body is lower. This is a brief pause in your long-term plan. Once you start titrating up through the Wegovy doses, you will reach an effective level again, and your progress should resume. Maintaining healthy eating and activity levels during this time can make a real difference.

Are the Mounjaro and Wegovy Pens Used the Same Way?

The basic technique is identical. Both are a once-weekly injection administered just under the skin (subcutaneously). The usual injection sites—your abdomen, the top of your thigh, or your upper arm—are the same for both.

The main practical difference is in the pens. Wegovy pens are single-use, pre-filled with one specific dose. You use it once and then dispose of it. In contrast, you may be used to the Mounjaro KwikPen, which is multi-dose and requires you to dial the correct amount for each injection. Your prescriber will ensure you receive clear instructions on using the Wegovy pen before your first dose.

Is There a Big Difference in Cost?

For many people in the UK, cost is a major factor in the decision to switch from Mounjaro to Wegovy. While prices are always subject to change, Wegovy has generally been a more affordable option in the UK private market, particularly when compared to the higher maintenance doses of Mounjaro.

When you make the switch, you will be starting on the Wegovy 0.25 mg dose, which is usually the lowest-priced pen. This can mean an immediate cost reduction from what you were paying for your Mounjaro prescription. It is best to have a frank discussion about pricing with your chosen online pharmacy so you know exactly what to expect.

At XO Medical, our UK-registered clinicians are dedicated to providing you with expert, supportive guidance on your weight management journey. If you are weighing up your options and considering a switch, we can help you do it safely. Start your free online consultation today to see if a change is the right move for you. https://xo-co.uk